Abstract
Fibrodysplasia ossificans progressiva (FOP), an extremely rare and catastrophic genetic disorder of progressive heterotopic ossification, is the most disabling condition of extraskeletal ossification known to mankind. It is also known as myositis ossificans progressiva. The incidence of FOP was estimated to be approximately 1 in 1.64 million (Connor and Evans 1982b).
Similar content being viewed by others
References
Al-Salmi, I., Raniga, S., & Al-Hadidi, A. (2014). Fibrodysplasia ossificans progressiva – Radiological findings: A case report. Oman Medical Journal, 29, 368–370.
Blaszczyk, M., Majewski, S., Brzezinska-Wcislo, L., et al. (2003). Fibrodysplasia ossificans progressiva. European Journal of Dermatology, 13, 234–237.
Brantus, J. F., & Meunier, P. J. (1998). Effects of intravenous etidronate and oral corticosteroids in fibrodysplasia ossificans progressiva. Clinical Orthopaedics, 346, 117–120.
Bridges, A. J., Hsu, K. C., Singh, A., et al. (1994). Fibrodysplasia (myositis) ossificans progressiva. Seminars in Arthritis and Rheumatism, 24, 155–164.
Carter, S. R., Davies, A. M., Evans, N., et al. (1989). Value of bone scanning and computed tomography in fibrodysplasia ossificans progressiva. British Journal of Radiology, 62, 269–272.
Carvalho, D. R., Navarro, M. M. M., Martins, M. J. A. F., et al. (2010). Mutational screening of ACVR1 gene in Brazilian fibrodysplasia ossificans progressiva patients. Clinical Genetics, 77, 171–176.
Cohen, M. M., Jr. (2002). Bone morphogenetic proteins with some comments on fibrodysplasia ossificans progressiva and NOGGIN. American Journal of Medical Genetics, 109, 87–92.
Cohen, R. B., Hahn, G. V., Tabas, J. A., et al. (1993). The natural history of heterotopic ossification in patients who have Fibrodysplasia ossificans progressiva. A study of forty-four patients. Journal of Bone and Joint Surgery (America), 75, 215–219.
Connor, J. M., & Evans, D. A. (1982a). Extra-articular ankylosis in fibrodysplasia ossificans progressiva. The British Journal of Oral Surgery, 20, 117–121.
Connor, J. M., & Evans, D. A. (1982b). Genetic aspects of fibrodysplasia ossificans progressiva. Journal of Medical Genetics, 19, 35–39.
Connor, J. M., & Evans, D. A. (1982c). Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. Journal of Bone and Joint Surgery (British), 64, 76–83.
Connor, J. M., & Smith, R. (1982). The cervical spine in fibrodysplasia ossificans progressiva. British Journal of Radiology, 55, 492–496.
Connor, J. M., Skirton, H., & Lunt, P. W. (1993). A three generation family with fibrodysplasia ossificans progressiva. Journal of Medical Genetics, 30, 687–689.
Cramer, S. F., Ruehl, A., & Mandel, M. A. (1981). Fibrodysplasia ossificans progressiva: A distinctive bone-forming lesion of the soft tissue. Cancer, 48, 1016–1021.
Cremin, B., Connor, J. M., & Beighton, P. (1982). The radiological spectrum of fibrodysplasia ossificans progressiva. Clinical Radiology, 33, 499–508.
Delatycki, M., & Rogers, J. G. (1998). The genetics of fibrodysplasia ossificans progressiva. Clinical Orthopaedics and Related Research, 346, 15–18.
Faruqi, T., Dhawan, N., Bahl, J., et al. (2014). Molecular, phenotypic aspects and therapeutic horizons of rare genetic bone disorders. BioMedical Research International, 2014, 1–16.
Feldman, G., Li, M., Martin, S., et al. (2000). Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31. American Journal of Human Genetics, 66, 128–135.
Groppe, J. C., Shore, E. M., & Kaplan, F. S. (2007). Functional modeling of the ACVR1 (R206H) mutation in FOP. Clinical Orthopaedics and Related Research, 462, 87–89.
Hall, J. G., Schaller, J. G., Worsham, N. G., et al. (1979). Fibrodysplasia ossificans progressiva (myositis ossificans progressiva) treatment with disodium etidronate. Journal of Pediatrics, 94, 679–680.
Herrera-Esparza, R., Pacheco-Tovar, D., Bollain-y-Goytia, J., et al. (2013). An activin receptor IA/activin-Like kinase-2 (R206H) mutation in fibrodysplasia ossificans progressiva. Case Reports in Genetics, 2013, 1–5.
Hüning, I., & Gillessen-Kaesbach, G. (2014). Fibrodysplasia ossificans progressiva: Clinical course, genetic mutations and genotype-phenotype correlation. Molecular Syndromology, 5, 201–211.
Janoff, H. B., Muenke, M., Johnson, L. O., et al. (1996). Fibrodysplasia ossificans progressiva in two half-sisters: Evidence for maternal mosaicism. American Journal of Medical Genetics, 61, 320–324.
Kaplan, F. S., & Glaser, D. L. (2005). Thoracic insufficiency syndrome in patients with fibrodysplasia ossificans progressiva. Clinical Reviews in Bone and Mineral Metabolism, 3, 213–216.
Kaplan, F. S., McCluskey, W., Hahn, G., et al. (1993). Genetic transmission of fibrodysplasia ossificans progressiva. Report of a family. Journal of Bone and Joint Surgery America, 75, 1214–1220.
Kaplan, F. S., Glaser, D. L., Shore, E. M., et al. (2005). The phenotype of: Fibrodysplasia ossificans progressiva. Clinical Reviews in Bone and Mineral Metabolism, 3, 183–188.
Kaplan, F. S., Glaser, D. L., Pignolo, R. J., et al. (2007). A new era for fibrodysplasia ossificans progressiva: A druggable target for the second skeleton. Expert Opinion on Biological Therapy, 7, 705–712.
Kaplan, F. S., Shen, Q., Lounev, V., et al. (2008). Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). Journal of Bone and Mineral Metabolism, 26, 521–530.
Kartal-Kaess, M., Shore, E. M., Xu, M., et al. (2010). Fibrodysplasia ossificans progressiva (FOP): Watch the great toes! European Journal of Pediatrics, 169(11), 1417–1421.
Kocyigit, H., Hizli, N., Memis, A., et al. (2001). A severely disabling disorder: Fibrodysplasia ossificans progressiva. Clinical Rheumatology, 20, 273–275.
Levy, C., Berner, T. F., Sandhu, P. S., et al. (1999). Mobility challenges and solutions for fibrodysplasia ossificans progressiva. Archives of Physical Medicine and Rehabilitation, 80, 1349–1353.
Liu, J.-X., Hu, R., Sun, Y., et al. (2014). General anesthesia in fibrodysplasia ossificans progressive: A case report and clinical review. International Journal of Clinical and Experimental Medicine, 7, 1474–1479.
Liu, H., Sawyer, S. L., Gos, M., et al. (2015). Atypical fibrodysplasia ossificans progressiva diagnosed by whole exome sequencing. American Journal of Medical Genetics Part A, 167A, 1337–1341.
Lucotte, G., Semonin, O., & Lutz, P. (1999). A de novo heterozygous deletion of 42 base-pairs in the noggin gene of a fibrodysplasia ossificans progressiva patient. Clinical Genetics, 56, 469–470.
Lucotte, G., Bathelier, C., Mercier, G., et al. (2000). Localization of the gene for fibrodysplasia ossificans progressiva (FOP) to chromosome 17q21-22. Genetic Counseling, 11, 329–334.
Maftei, C., Rypens, F., Thiffault, I., et al. (2015). Fibrodysplasia ossificans progressiva: Bilateral hallux valgus on ultrasound a clue for the first prenatal diagnosis for this condition – Clinical report and review of the literature. Prenatal Diagnosis, 35, 305–307.
Mahboubi, S., Glaser, D. L., Shore, E. M., et al. (2001). Fibrodysplasia ossificans progressiva. Pediatric Radiology, 31, 307–314.
Pachajoa, H., & Botero, A. F. (2015). Clinical and molecular characterisation of two siblings with fibrodysplasia ossificans progressiva, from the Colombian Pacific coast (South America). BMJ Case Reports, 2015, 1–6.
Pawar, S. U., Sahoo, S., Manglunia, A., et al. (2015). Fibrodysplasia ossificance progressiva: A familial presentation. Indian Journal of Nuclear Medicine, 30, 290–291.
Pignolo, R. J., Shore, E. M., & Kaplan, F. S. (2013). Fibrodysplasia ossificans progressiva: Diagnosis, management, and therapeutic horizons. Pediatric Endocrinology Reviews, 10, 437–448.
Rogers, J. G., & Geho, W. B. (1979). Fibrodysplasia ossificans progressiva. A survey of forty-two cases. Journal of Bone and Joint Surgery America, 61, 909–914.
Schroeder, H. W., Jr., & Zasloff, M. (1980). The hand and foot malformations in fibrodysplasia ossificans progressiva. The Johns Hopkins Medical Journal, 147, 73–78.
Sémonin, O., Fontaine, K., Daviaud, C., et al. (2001). Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. American Journal of Medical Genetics, 102, 314–317.
Shafritz, A. B., Shore, E. M., Gannon, F. H., et al. (1996). Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. The New England Journal of Medicine, 335, 555–561.
Shore, E. M., & Kaplan, F. S. (2005). Fibrodysplasia ossificans progressiva and progressive osseous heteroplasia. Clinical Reviews in Bone and Mineral Metabolism, 3, 257–259.
Shore, E. M., Xu, M., Feldman, G. J., et al. (2006). A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nature Genetics, 38, 525–527.
Smith, R. (1998). Fibrodysplasia (myositis) ossificans progressiva. Clinical lessons from a rare disease. Clinical Orthopaedics and Related Research, 346, 7–14.
Taslimi, R., Jafarpour, S., & Hassanpour, N. (2015). FOP: Still turning into stone. Clinical Rheumatology, 34, 379–384.
Tulchinsky, M. (2007). Diagnostic features of fibrodysplasia (myositis) ossificans progressiva on bone scan. Clinical Nuclear Medicine, 32, 616–619.
Virdi, A. S., Shore, E. M., Oreffo, R. O., et al. (1999). Phenotypic and molecular heterogeneity in fibrodysplasia ossificans progressiva. Calcified Tissue International, 65, 250–255.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this entry
Cite this entry
Chen, H. (2017). Fibrodysplasia Ossificans Progressiva. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2401-1_93
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2401-1_93
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2400-4
Online ISBN: 978-1-4939-2401-1
eBook Packages: MedicineReference Module Medicine